Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.32 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Anebulo Pharmaceuticals (ANEB) Net Equity Issued and Repurchased (2022)

Updated

Anebulo Pharmaceuticals (ANEB) recorded Net Equity Issued and Repurchased of $15 million in FY2025 (year ended Jun 30, 2025).

Analysis

Anebulo Pharmaceuticals (ANEB) Net Equity Issued and Repurchased (2022) Analysis & Trends

Starting with FY2020, Anebulo Pharmaceuticals' Net Equity Issued and Repurchased history includes 4 fiscal years.

  • Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 46.1% (FY2020 to FY2025).
  • The FY2025 figure is the highest annual Net Equity Issued and Repurchased since FY2021.
  • Per Business Quant data, ANEB's Net Equity Issued and Repurchased was $6.65 million in FY2023 and $20.6 million in FY2021 (+815.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Anebulo Pharmaceuticals 13.15 Mn 13.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 6.65 Mn
API Access

Anebulo Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ANEB&period=max&api_key=YOUR_API_KEY